Comments on: Novartis ribociclib Phase III NATALEE trial meets primary endpoint at interim analysis /213754/novartis-ribociclib-phase-iii-natalee-trial-meets-primary-endpoint-at-interim-analysis Mon, 24 Apr 2023 17:06:56 +0800 hourly 1 https://wordpress.org/?v=6.5.5